1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
1 of 4
FEATURED COMPANIES
- Amgen
- F. Hoffmann-La Roche
- Johnson & Johnson
- Merck & Co
- Pfizer
- MORE
About Biologics
Biologics, biopharmaceutical, biologic drugs, or biological drugs refer to drugs that are extracted, synthesized, and manufactured from biological material derived from living sources, such as humans, plants, and animals. Biologics manufacturing refers to the production of such drugs.
The analysts forecast the Global Biologics Manufacturing Market to grow at a CAGR of 9.11% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the biologics manufacturing market. To calculate the market size, the report considers the cost incurred for in-house manufacturing of biologics and the revenue generated by contract manufacturers of biologics across the globe.
The market is divided into the following segments based on geography:
Key vendors
Biologics, biopharmaceutical, biologic drugs, or biological drugs refer to drugs that are extracted, synthesized, and manufactured from biological material derived from living sources, such as humans, plants, and animals. Biologics manufacturing refers to the production of such drugs.
The analysts forecast the Global Biologics Manufacturing Market to grow at a CAGR of 9.11% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the biologics manufacturing market. To calculate the market size, the report considers the cost incurred for in-house manufacturing of biologics and the revenue generated by contract manufacturers of biologics across the globe.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
Key vendors
- Amgen
- F. Hoffmann-La Roche
- Johnson & Johnson
- Merck & Co
- Pfizer
- Introduction of new biologic drugs for treating diseases
- For a full, detailed list, view the full report
- High cost of branded drugs is deterring market growth
- For a full, detailed list, view the full report
- Rise in partnerships between traditional biopharma companies and biotechnology startups
- For a full, detailed list, view the full report
- What will the market size be in 2022 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the Key vendors in this market space?
- What are the market opportunities and threats faced by the Key vendors?
- What are the strengths and weaknesses of the Key vendors?
Note: Product cover images may vary from those shown
2 of 4
FEATURED COMPANIES
- Amgen
- F. Hoffmann-La Roche
- Johnson & Johnson
- Merck & Co
- Pfizer
- MORE
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
PART 10: REGIONAL LANDSCAPE
PART 12: DRIVERS AND CHALLENGES
Exhibit 01: Related market
Exhibit 02: Market characteristics
Exhibit 03: Market segments
Exhibit 04: Market definition - Inclusions and exclusions checklist
Exhibit 05: Market size 2017
Exhibit 06: Validation techniques employed for market sizing 2017
Exhibit 07: Global – Market size and forecast 2017-2022 ($ bn)
Exhibit 08: Global – Year-over-year growth 2018-2022 (%)
Exhibit 09: Five forces analysis 2017
Exhibit 10: Five forces analysis 2022
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2017
Exhibit 17: Technology – Market share 2017-2022 (%)
Exhibit 18: Comparison by technology
Exhibit 19: In-house – Market size and forecast 2017-2022 ($ bn)
Exhibit 20: In-house – Year-over-year growth 2018-2022 (%)
Exhibit 21: Outsourced – Market size and forecast 2017-2022 ($ bn)
Exhibit 22: Outsourced – Year-over-year growth 2018-2022 (%)
Exhibit 23: Market opportunity by technology
Exhibit 24: Product – Market share 2017-2022 (%)
Exhibit 25: Comparison by product
Exhibit 26: Biologics – Market size and forecast 2017-2022 ($ bn)
Exhibit 27: Biologics – Year-over-year growth 2018-2022 (%)
Exhibit 28: Biosimilars – Market size and forecast 2017-2022 ($ bn)
Exhibit 29: Biosimilars – Year-over-year growth 2018-2022 (%)
Exhibit 30: Market opportunity by product
Exhibit 31: Customer landscape
Exhibit 32: Global – Market share by geography 2017-2022 (%)
Exhibit 33: Regional comparison
Exhibit 34: Americas – Market size and forecast 2017-2022 ($ bn)
Exhibit 35: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 36: EMEA – Market size and forecast 2017-2022 ($ bn)
Exhibit 37: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 38: APAC – Market size and forecast 2017-2022 ($ bn)
Exhibit 39: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 40: Key leading countries
Exhibit 41: Market opportunity
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: Amgen: Overview
Exhibit 48: Amgen – Business segments
Exhibit 49: Amgen – Organizational developments
Exhibit 50: Amgen – Geographic focus
Exhibit 51: Amgen – Key offerings
Exhibit 52: F. Hoffmann-La Roche: Overview
Exhibit 53: F. Hoffmann-La Roche– Business segments
Exhibit 54: F. Hoffmann-La Roche – Organizational developments
Exhibit 55: F. Hoffmann-La Roche– Geographic focus
Exhibit 56: F. Hoffmann-La Roche– Segment focus
Exhibit 57: F. Hoffmann-La Roche – Key offerings
Exhibit 58: Johnson & Johnson: Overview
Exhibit 59: Johnson & Johnson– Business segments
Exhibit 60: Johnson & Johnson – Organizational developments
Exhibit 61: Johnson & Johnson – Geographic focus
Exhibit 62: Johnson & Johnson – Segment focus
Exhibit 63: Johnson & Johnson – Key offerings
Exhibit 64: Merck & Co.: Overview
Exhibit 65: Merck & Co. – Business segments
Exhibit 66: Merck & Co. – Organizational developments
Exhibit 67: Merck & Co. – Geographic focus
Exhibit 68: Merck & Co. – Segment focus
Exhibit 69: Merck & Co. – Key offerings
Exhibit 70: Pfizer: Overview
Exhibit 71: Pfizer – Business segments
Exhibit 72: Pfizer – Organizational developments
Exhibit 73: Pfizer – Geographic focus
Exhibit 74: Pfizer – Segment focus
Exhibit 75: Pfizer – Key offerings
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Market definition
- Market sizing 2017
- Market size and forecast 2017-2022
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
- Segmentation by technology
- Comparison by technology
- In-house – Market size and forecast 2017-2022
- Outsourced – Market size and forecast 2017-2022
- Market opportunity by technology
- Segmentation by product
- Comparison by product
- Biologics – Market size and forecast 2017-2022
- Biosimilars – Market size and forecast 2017-2022
- Market opportunity by product
PART 10: REGIONAL LANDSCAPE
- Geographical segmentation
- Regional comparison
- Americas – Market size and forecast 2017-2022
- EMEA – Market size and forecast 2017-2022
- APAC – Market size and forecast 2017-2022
- Key leading countries
- Market opportunity
PART 12: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
- Rise in partnerships between traditional biopharma companies and biotechnology startups
- Growing outsourcing of biologics manufacturing
- Increase in FDA approvals for new biologics products
- Overview
- Landscape disruption
- Competitive scenario
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Amgen
- F. Hoffmann-La Roche
- Johnson & Johnson
- Merck & Co.
- Pfizer
- List of abbreviations
Exhibit 01: Related market
Exhibit 02: Market characteristics
Exhibit 03: Market segments
Exhibit 04: Market definition - Inclusions and exclusions checklist
Exhibit 05: Market size 2017
Exhibit 06: Validation techniques employed for market sizing 2017
Exhibit 07: Global – Market size and forecast 2017-2022 ($ bn)
Exhibit 08: Global – Year-over-year growth 2018-2022 (%)
Exhibit 09: Five forces analysis 2017
Exhibit 10: Five forces analysis 2022
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2017
Exhibit 17: Technology – Market share 2017-2022 (%)
Exhibit 18: Comparison by technology
Exhibit 19: In-house – Market size and forecast 2017-2022 ($ bn)
Exhibit 20: In-house – Year-over-year growth 2018-2022 (%)
Exhibit 21: Outsourced – Market size and forecast 2017-2022 ($ bn)
Exhibit 22: Outsourced – Year-over-year growth 2018-2022 (%)
Exhibit 23: Market opportunity by technology
Exhibit 24: Product – Market share 2017-2022 (%)
Exhibit 25: Comparison by product
Exhibit 26: Biologics – Market size and forecast 2017-2022 ($ bn)
Exhibit 27: Biologics – Year-over-year growth 2018-2022 (%)
Exhibit 28: Biosimilars – Market size and forecast 2017-2022 ($ bn)
Exhibit 29: Biosimilars – Year-over-year growth 2018-2022 (%)
Exhibit 30: Market opportunity by product
Exhibit 31: Customer landscape
Exhibit 32: Global – Market share by geography 2017-2022 (%)
Exhibit 33: Regional comparison
Exhibit 34: Americas – Market size and forecast 2017-2022 ($ bn)
Exhibit 35: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 36: EMEA – Market size and forecast 2017-2022 ($ bn)
Exhibit 37: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 38: APAC – Market size and forecast 2017-2022 ($ bn)
Exhibit 39: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 40: Key leading countries
Exhibit 41: Market opportunity
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: Amgen: Overview
Exhibit 48: Amgen – Business segments
Exhibit 49: Amgen – Organizational developments
Exhibit 50: Amgen – Geographic focus
Exhibit 51: Amgen – Key offerings
Exhibit 52: F. Hoffmann-La Roche: Overview
Exhibit 53: F. Hoffmann-La Roche– Business segments
Exhibit 54: F. Hoffmann-La Roche – Organizational developments
Exhibit 55: F. Hoffmann-La Roche– Geographic focus
Exhibit 56: F. Hoffmann-La Roche– Segment focus
Exhibit 57: F. Hoffmann-La Roche – Key offerings
Exhibit 58: Johnson & Johnson: Overview
Exhibit 59: Johnson & Johnson– Business segments
Exhibit 60: Johnson & Johnson – Organizational developments
Exhibit 61: Johnson & Johnson – Geographic focus
Exhibit 62: Johnson & Johnson – Segment focus
Exhibit 63: Johnson & Johnson – Key offerings
Exhibit 64: Merck & Co.: Overview
Exhibit 65: Merck & Co. – Business segments
Exhibit 66: Merck & Co. – Organizational developments
Exhibit 67: Merck & Co. – Geographic focus
Exhibit 68: Merck & Co. – Segment focus
Exhibit 69: Merck & Co. – Key offerings
Exhibit 70: Pfizer: Overview
Exhibit 71: Pfizer – Business segments
Exhibit 72: Pfizer – Organizational developments
Exhibit 73: Pfizer – Geographic focus
Exhibit 74: Pfizer – Segment focus
Exhibit 75: Pfizer – Key offerings
Note: Product cover images may vary from those shown
3 of 4
LOADING...
4 of 4
FEATURED COMPANIES
- Amgen
- F. Hoffmann-La Roche
- Johnson & Johnson
- Merck & Co
- Pfizer
- MORE
New Report Released: - Global Biologics Manufacturing Market 2018-2022
The author of the report recognizes the following companies as the key players in the global biologics manufacturing market: Amgen, F. Hoffmann-La Roche, Johnson & Johnson, Merck & Co, and Pfizer.
Commenting on the report, an analyst from the research team said: “One trend affecting this market is the rise in partnerships between traditional biopharma companies and biotechnology startups. The significant growth of the biologics industry and biotech companies in the past few years has encouraged several major traditional biopharma companies to collaborate with biotechnology startups to develop novel biologics drugs.”
According to the report, one driver influencing this market is the introduction of new biologic drugs for treating diseases. There is a growing demand for biologics for effective treatment of diseases as synthetic drugs have several limitations.
Further, the report states that one challenge affecting this market is the high cost of branded drugs is deterring market growth. A key factor restraining the growth of the global biologics manufacturing market is the high cost of medication.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
The author of the report recognizes the following companies as the key players in the global biologics manufacturing market: Amgen, F. Hoffmann-La Roche, Johnson & Johnson, Merck & Co, and Pfizer.
Commenting on the report, an analyst from the research team said: “One trend affecting this market is the rise in partnerships between traditional biopharma companies and biotechnology startups. The significant growth of the biologics industry and biotech companies in the past few years has encouraged several major traditional biopharma companies to collaborate with biotechnology startups to develop novel biologics drugs.”
According to the report, one driver influencing this market is the introduction of new biologic drugs for treating diseases. There is a growing demand for biologics for effective treatment of diseases as synthetic drugs have several limitations.
Further, the report states that one challenge affecting this market is the high cost of branded drugs is deterring market growth. A key factor restraining the growth of the global biologics manufacturing market is the high cost of medication.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
- Amgen
- F. Hoffmann-La Roche
- Johnson & Johnson
- Merck & Co
- Pfizer
Note: Product cover images may vary from those shown
